4//SEC Filing
Rogers Erica J. 4
Accession 0001593968-23-001343
CIK 0001397702other
Filed
Sep 28, 8:00 PM ET
Accepted
Sep 29, 6:00 PM ET
Size
5.4 KB
Accession
0001593968-23-001343
Insider Transaction Report
Form 4
Rogers Erica J.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2021-03-02$56.62/sh−1,651$93,478→ 267,988 total
Footnotes (2)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on September 11, 2020, prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
- [F2]This transaction was executed in multiple trades at price ranging from $56.55 to $56.70. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Silk Road Medical Inc
CIK 0001397702
Entity typeother
Related Parties
1- filerCIK 0001769940
Filing Metadata
- Form type
- 4
- Filed
- Sep 28, 8:00 PM ET
- Accepted
- Sep 29, 6:00 PM ET
- Size
- 5.4 KB